# Baclofen for the Treatment of Alcohol Drinkers

> **NCT01604330** · PHASE2,PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 323 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** Baclofen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01604330
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-29
- **Primary completion:** 2014-09
- **Final completion:** 2015-10
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01604330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01604330, "Baclofen for the Treatment of Alcohol Drinkers". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01604330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*